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Spectrophotometric analysisAbstract A new simple, accurate and cost-effective spectrophotometric method has been devel-
oped for the analysis of some cephalosporins (ceftriaxone, ceftazidime, ceﬁxime, cefotaxime and
cefuroxime) in bulk samples and pharmaceutical dosage forms. The reaction involves a two-step
process of diazotization of the cephalosporins with acidiﬁed NaNO2 at 0–5 C and coupling with
acidiﬁed p-dimethylaminobenzaldehyde (DMAB). Optimal temperature and time for coupling were
established at 50 and 60 C with coupling time ranging from 15 to 20 min. All the cephalosporins
gave azo adducts with DMAB that absorbed light optimally at 400–430 nm. The reaction with
DMAB occurred at a stoichiometric ratio of 1:1. Optimization of DMAB concentration revealed
the superiority of using 0.3% DMAB in 0.0625 M H2SO4 with the best diluting solvent being meth-
anol. Beer’s law was obeyed at concentrations ranging from 5 to 60 lg/mL with correlation coefﬁ-
cients >0.9980 in all cases. Overall recoveries were of the order of 95–103% with errors generally
less than 6%. The method was successfully applied to the determination of the cephalosporins in
dosage forms and it was found to be equivalent accuracy to the ofﬁcial (USP and BP) HPLC assay
procedures for these drugs. There was no interference from commonly adopted excipients.
The method could ﬁnd application as a rapid and cost-effective alternative for the quality control
of these cephalosporins, especially in preliminary studies.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cephalosporins are a class of b-lactam antibiotics discovered
in the 1950’s and are produced by various species of the mold
Cephalosporium and from semi-synthetic processes. Cephalo-
sporin-C which is the prototype of the cephalosporins was iso-
lated in 1956 by Norton and Abraham from Cephalosporium
acremorium, and its total synthesis was accomplished by
Woodward and co-workers in 1966. Cephalosporins are broad
spectrum antibiotics, with high potency against Gram-negative
Novel spectrophotometric determinations of some cephalosporins following azo dye S1273organisms. They are more resistant to inactivation by b-lacta-
mases, particularly those produced by Gram-positive bacteria.
They also have relatively low serum protein binding potential
and almost all are excreted through the renal route. The ceph-
alosporins are generally used in the treatment of upper respira-
tory and urinary tract infections. They are also generally useful
for the rare patient who is sensitive to penicillin although sen-
sitivity to cephalosporins is also sometimes found (Delgado
and Remers, 2004; Dollery, 1999). The basic nucleus of the
cephalosporins is 7-amino-cephalosporanic acid (7-ACA),
which comprises a dihydrothiazine nucleus and a b-lactam
ring. Cephalosporins are traditionally divided into ﬁrst, sec-
ond, third and fourth generation agents, based roughly on
the time of their discovery and their antimicrobial properties
i.e. spectrum of activity.
The ofﬁcial methods for the analysis of the cephalosporins
are HPLC techniques in the reversed phase mode (BP, 2009;
USP, 2009). Various other alternative methods have been re-
ported for the analyzes of the cephalosporins. The methods in-
clude spectrophotometric (Abdel-Hamid, 1998; Kelani et al.,
1998; El-Walily et al., 2000a,b; Agbaba et al., 1997; Yang
et al., 1998), spectroﬂuorometric (Aly et al., 1996; Yang et al.,
1999; Hefnawy et al., 1999; El-Walily et al., 1999), chemilumi-
nescence (Li and Lu, 2006; Yao et al., 2003; Thongpoon
et al., 2006), chromatographic (Shinde and Shabadi, 1997,
1998;Misztal, 1998; LaCourse andDasenbrock, 1999) and elec-
trochemical methods (O¨zkan et al., 2000; Rodrigues et al., 1999;
El-Maali et al., 1993; Ferreira et al., 1999). There are many
methods which have been reported based on the hydrolysis of
cephalosporins to the residual 7-ACA for the assay of cephalo-
sporins in both bulk samples and pharmaceutical dosage forms.
These methods include use of derivatization of the a-aminoacyl
functions (El-Obeid et al., 1999), ﬂow injection analysis follow-
ing formation of dyes (Metwally et al., 2001), iodine and wool
fast blue (Sastry et al., 1998), alkaline hydrolysis (Helaleh and
Abu-Nameh, 1998), ﬂow injection (Al-Momani, 2004), vanado-
phosphoric acid (Amin and Shama, 2000) and more recently 4-
chloro-7-nitrobenzo-2-oxa-1,3-diazole (Rageh et al., 2010).
While each of these reported methods has advantages, majority
of them are extensively time-consuming and utilizes reagents
which are expensive or may in some cases present with certain
stability problems.
Recently, we demonstrated the ability of p-dimethylamino-
benzaldehyde (DMAB) to form azo dyes with diazotizable
functional groups and we successfully adopted the method
for the spectrophotometric determination of metronidazole
and tinidazole with accuracies comparable to ofﬁcial methods
(Adegoke and Umoh, 2009). Generic brands of cephalospo-
rins circulating in the drug market have become too over-
whelming in recent times that a simple, rapid and equally
accurate method will be required for their quality assessment.
In this report, we developed simple approaches for the spec-
trophotometric determination of ﬁve cephalosporins possess-
ing amino groups that can be diazotized and coupled to
acidic solution of DMAB in methanol with a view to provid-
ing relatively simple and easily adoptable technique for their
analysis with the use of cheap reagents. The drug market has
witnessed the proliferation of many multisource generic
brands of cephalosporins in the last decade. The ofﬁcial
method for their assay is HPLC which is beyond the reach
of the third world economies. A simple spectrophotometricmethod with readily available reagent will aid in the quality
control of these anti-bacterials.2. Experimental
2.1. Reagents and materials
Cefuroxime (CEFU), ceﬁxime (CEFM), ceftazidime (CEZD),
ceftriaxone (CEFT) and cefotaxime (CEFX) chemical reference
substances. Methanol, ethyl acetate, acetone, sulfuric acid,
sodium nitrite, distilled water, ethanol, lactose, starch, magne-
sium stearate, talc, gelatin, p-dimethylaminobenzaldehyde
(DMAB), hydrochloric acid (all analytical reagent grade from
BDH, Poole, England).
Drug samples consisted of cefuroxime injection, cefuroxime
tablets, ceﬁxime tablets, ceftazidime injection, ceftriaxone
injection, cefotaxime injection.2.2. Equipment
Analytical balance (Mettler AE 160, Mettler PC 400), thermo-
stated water bath (Buchi, Switzerland), vortex mixer (Grifﬁns
and George Ltd., UK), UV–vis spectrophotometer (Lambda
25 UV/VIS Spectrometer, Perkin Elmer Inc., Singapore),
HPLC equipment (Cecil adept system 4-programmable
wavelength detector CE 4200, dual piston pump CE 4100,
chromatographic system manager CE 4900, auto sampler CE
4800).
2.3. Preparation of stock solutions
2.3.1. Preparation of DMAB solution
A 0.3% solution of p-dimethylaminobenzaldehyde (DMAB)
was prepared by dissolving 0.3 g of the crystals in 100 mL of
0.0625 M sulfuric acid to give a molarity of 0.02013 M.2.3.2. Preparation of drug stock solution
Equimolar concentrations (0.02013 M) of the ﬁve cephalospo-
rins were prepared by dissolving 11.14 mg (CEFT), 8.54 mg
(CEFU), 10.99 mg (CEFD), 9.16 mg (CEFX) and 9.12 mg
(CEFM) in 10 mL of methanol to obtain the respective stock
solutions.
2.3.3. Preparation of sodium nitrite solution
A 10% solution of sodium nitrite was prepared by dissolving
1 g of sodium nitrite crystal, (activated at 105 C for 1 h in
the oven) in 10 mL of distilled water.2.3.4. Preparation of diazotized drugs
A 0.3 mL aliquot of the 10% of solution of sodium nitrite was
added to a mixture of 0.3 mL of the drug stock solution and
0.12 mL of HCl solution was then added and the mixture
cooled. The diazotization was carried out with stirring for
20 min. The reaction was stopped by the addition of 13 mL
of ice-cold water and the mixture was allowed to stand in ice
for 15 min before use. All the drug samples are diazotized in
similar manner.
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Figure 1 Structures of the cephalosporins studied.
Figure 2 Overlaid absorption spectra of azo adducts formed
between the cephalosporins and DMAB.
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A 0.5 mL aliquot of DMAB solution was pipetted into a test
tube and 0.5 mL of the diazotized drug solution was added.
The immediate yellow colored complex formed was allowed
to stay at room temperature 30 and 70 C for 5 min. The solu-
tion was made up to 5 mL with methanol. The absorption of
the azo adduct at different wavelength ranging from 200 to
700 nm was recorded by scanning on a UV–vis spectropho-
tometer against methanol as solvent blank. The wavelength
with the highest absorption was noted. This procedure was
carried out with the different diazotized drug solutions.
2.5. Optimization studies
2.5.1. Optimization of reaction temperature and time
The method of steepest ascent was adopted for this assessment
(Karnes and March, 1993). Aliquots of the diazotized drug
solution (0.5 mL) was added to 0.5 mL DMAB solution in test
tubes and the reaction mixtures were mixed in a vortex mixer
followed by incubation at 30, 50, 60 and 80 C for 5 and
20 min. Each determination was done in duplicate. The absor-
bance readings of the complex were taken at their respective
wavelength maxima after making them up to 5 mL with meth-
anol. The optimal temperature was taken as the temperature
corresponding to the maximal absorbance of the samples.
For the optimization of reaction time, aliquots of the diazo-
tized drug solution (0.5 mL) was added to 0.5 mL DMAB solu-tion in test tubes and the reaction mixtures were mixed in a
vortexmixer followed by incubation at 50 C (CEFT andCEFX
adducts) and 60 C (CEZD, CEFM and CEFU adducts). The
reaction was terminated by making up to 5 mL with methanol
at 5, 10, 15, 20, 25 and 30 min and cooling in ice-bath. Each
determination was done in duplicate. The absorbance readings
of the complex were taken at their respective wavelength max-
ima and the optimal reaction time was taken as the time corre-
sponding to the maximal absorbance of the samples.
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Scheme 1 Proposed coupling patterns for the azo dye formation.
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The effect of varying the concentration of the acid used in
the preparation of the DMAB solution on the azo adduct
formation was studied by preparing DMAB reagent solu-
tion with 0.00156, 0.0312, 0.0625, 0.125, 0.25, 0.5, 1.0 and
2.0 M sulfuric acid. In each case, the absorbance reading
of each reaction mixture containing 0.5 mL DMAB and0.5 mL diazotized drug solution incubated at optimized tem-
perature and time was taken. Optimal acid concentration
was taken as one which gave the highest absorbance
reading.
In order to determine the effect of the solvent used in
stopping the coupling reaction, water, ethanol, propan-1-ol,
propan-2-ol and methanol were each used as the diluting sol-
Figure 3 Optimization of coupling reaction temperature; (a) for ceftriaxone, ceftazidime and ceﬁxime. (b) For cefotaxime and
cefuroxime.
Figure 4 Optimization of coupling reaction time at 50 C for
ceftriaxone and cefotaxime.
Figure 5 Optimisation of coupling reaction time at 60 C for
ceftazidime, ceﬁxime and cefuroxime.
S1276 O.A. Adegoke, M.O. Quadrivent. The different solvents were used to make up the reaction
mixture (0.5 mL DMAB and 0.5 mL diazotized drug solution)
to volume after incubation at the optimal temperature and
time). In each case, the absorbance reading of the resulting
mixture was taken at their respective wavelength maxima.
The effect of varying the concentration of DMAB was car-
ried out using reagent concentrations of 0.1%, 0.2%, 0.3%,
0.5%, 1.0%, 2.0% and 3.0% in 0.0625 M H2SO4. After mixing
0.5 mL of each reagent concentration with 0.5 mL of the diaz-
otized drug solution and incubating at speciﬁc temperature
and time, the reaction mixture was made up to 5 mL with
methanol. The absorbance readings of the complex formed
were determined at their respective wavelength maxima.
2.5.3. Stoichiometric ratio determination
Job’s method of continuous variation (Rose, 1964) was
adopted for this study. Equimolar solutions (0.02013 M) of
DMAB and diazotized drug solution were prepared in their
respective solvents. Into ten different test tubes, 0, 0.2, 0.3,0.4, 0.5, 0.6, 0.7, 0.75, 0.8 and 1 mL of DMAB was added,
respectively. The solutions were made up to 1.0 mL with the
diazotized drug solution. The mixtures were incubated at dif-
ferent temperature and time made up to 5 mL with methanol
and the absorbance readings were determined.
2.6. Validation studies
The calibration curves were prepared using concentrations of
the diazotized drugs ranging from 0 to 60 lg/mL, depending
on the cephalosporin. 0.5 mL of DMAB was added to each
of these test tubes. These test tubes were incubated at different
temperature and time (speciﬁc for the different drugs used),
after which respective volumes of methanol were added to
make up to 5 mL reaction mixture. The absorbance readings
of each of the mixture were then recorded at their respective
wavelength maxima. The average absorbance reading was ob-
tained from the determinations, and used to generate the cali-
bration curves. Calibration curves were prepared on three
successive days. The particular range for each diazotized drug
Table 1 Analytical and validation parameters for the analysis of the cephalosporins.
Parameter CEFT CEZD CEFM CEFX CEFU
Color at room temperature Deep yellow Golden yellow Yellow Yellow Golden yellow
Color at 70 C (5 min) Deep orange Deep orange Deep orange Deep orange Deep orange
kmax (nm) 420 420 430 400 420
Limit of detection (lg mL1) 5.093 1.901 6.152 1.775 1.751
Limit of quantitation (lg mL1) 15.44 5.76 18.64 5.38 5.84
Molar absorptivity (mol1 cm2) (9.25 ± 0.14) · 104 (1.033 ± 0.088) · 103 (9.91 ± 0.53) · 102 (8.488 ± 0.209) · 102 (1.143 ± 0.001) · 104
Table 2 Regression analysis for the calibration data.a
Parameter CEFT CEZD CEFM CEFX CEFU
Beer’s law range (lg mL1) 25–60 5–35 30–55 20–45 10–40
Slope 0.006348 0.01701 0.005256 0.01822 0.01679
95% Conﬁdence interval for slope 5.62 · 104 5.36 · 104 1.273 · 103 4.35 · 103 2.20 · 103
Intercept 0.3822 0.0623 0.475 0.0327 0.0826
95% Conﬁdence interval for intercept 2.51 · 102 9.5 · 103 5.36 · 102 5.51 · 103 7.92 · 104
Correlation coeﬃcient (r) 0.9991 0.9993 0.9982 0.9988 0.9995
Coeﬃcient of determination (r2) 0.9982 0.9986 0.9964 0.9976 0.9990
a y= bx+ c; where y is the absorbance, x is the concentration.
Table 3 Intra-day accuracy and precision of the new method.
Drug Amount taken (lg mL1) Amount found (lg mL1) Recoverya (%) RSDb (%) Relative error (%)
CEFT 25.0 25.26 101.04 2.69 1.03
40.0 40.03 100.08 1.65 0.08
50.0 49.87 99.74 0.68 0.26
CEZD 10.0 10.15 101.98 2.4 1.94
20.0 20.64 103.18 1.19 3.08
30.0 30.04 100.13 0.81 0.13
CEFM 30.0 29.97 99.9 1.58 0.1
40.0 40.43 101.08 0.85 1.06
55.0 55.66 101.2 0.85 1.19
CEFX 25.0 25.20 100.78 0.913 0.77
35.0 35.56 101.6 0.79 1.57
45.0 45.03 100.07 0.30 0.07
CEFU 15.0 15.41 102.71 0.84 2.66
25.0 26.50 106.0 0.57 5.66
35.0 34.55 98.71 0.38 1.29
a Average of six determinations.
b RSD, relative standard deviation.
Novel spectrophotometric determinations of some cephalosporins following azo dye S1277was arrived at by carrying out linear regression analysis of the
results obtained from linearity of response. The range that
gave the best slope, least intercept and highest correlation coef-
ﬁcient was adopted for each cephalosporin.
Accuracy and repeatability of the new methods were carried
out in 3 successive days as stipulated by the USP (USP, 2000).
Other validation parameters were assessed using the ICH
guidelines (ICH Topic Q2, 2010). The limit of detection
(LOD) and limit of quantitation (LOQ) were obtained from
the ICH guidelines using the expressions:
LOD ¼ 3:3r
s
and LQD ¼ 10r
s
where r is the standard deviation of the blank signals and s is
the slope of the calibration graph.2.7. Dosage form analysis
2.7.1. New method
Various dosage forms, mainly tablets and powder for injection,
were sourced from retail outlets and assessed for their content
of the cephalosporins using the new DMAB method and the
ofﬁcial HPLC assay procedures for each cephalosporin. In
each instance, stock solutions were made containing the equiv-
alent of each cephalosporin to give a molarity of 0.02013 M
and then diazotization of the dosage form was carried out as
done for the pure cephalosporins. For ceftazidime, the follow-
ing brands were studied – Orzid Injection and Betazidim
Injection 0.1 mL (equivalent to 20 lg/mL of ceftazidime) of
the diazotized drug solution were reacted with 0.5 mL DMAB
Table 4 Inter-day accuracy and precision of the new method.
Drug Amount taken (lg mL1) Amount found (lg mL1) Recoverya (%) RSDb (%) Relative error (%)
CEFT 25.0 25.46 101.84 2.55 1.81
40.0 40.82 102.05 2.25 2.01
50.0 49.68 99.36 0.79 0.64
CEZD 10.0 10.15 101.49 2.21 1.47
20.0 20.78 103.89 1.03 3.74
30.0 20.94 99.81 1.01 0.19
CEFM 30.0 30.36 101.20 2.34 1.19
40.0 40.59 101.48 1.11 1.15
55.0 55.73 101.33 0.84 1.31
CEFX 25.0 25.44 101.76 1.26 1.73
35.0 35.53 101.51 1.07 1.49
45.0 45.03 100.67 0.31 0.07
CEFU 15.0 15.51 103.37 1.23 3.26
25.0 26.60 106.40 0.79 6.02
35.0 35.90 102.57 2.7 2.51
a Average of twelve determinations.
b RSD, relative standard deviation.
S1278 O.A. Adegoke, M.O. Quadriand incubated at 60C for 20 min. The solutions were made
up to 5 mL with methanol and their absorbance values
recorded.
For cefuroxime, the following brands were studied – Axa-
cef 500 mg tablets, Zocef 750 mg, Roxicef 750 mg injec-
tions. One hundred and twenty ﬁve microliter (equivalent to
25 lg/mL cefuroxime) of the diazotized drug solutions reacted
with 0.5 mL DMAB and incubated at 60 C for 20 min.
For ceftriaxone, the following brands were studied – Duo-
cef 1 g, Rophex 1 g and Ebecef 1 g injections. 0.2 mL
(equivalent to 40 lg/mL ceftriaxone) of the diazotized drug
solutions were reacted with 0.5 mL DMAB and incubated at
50 C for 20 min. The solutions were made up to 5 mL with
methanol and their absorbances recorded.
For ceﬁxime, two tablet brands were studied. 0.2 mL
(equivalent to 40 lg/mL ceﬁxime) of the diazotized drug solu-
tion were reacted with 0.5 mL DMAB and incubated at 60 C
for 20 min. The solutions were made up to 5 mL with metha-
nol and their absorbances recorded.
For cefotaxime, the following brands were studied – Nitax-
im 1 g and Taxim 500 mg injections. 0.175 mL (equivalent
to 35 lg/mL cefotaxime) of the diazotized drug solutions were
reacted with 0.5 mL DMAB and incubated at 50 C for
20 min. The solutions were made up to 5 mL with methanol
and their absorbances recorded. The analyzes above were car-
ried out in six replicates.
2.7.2. Ofﬁcial method
The analyzes of the different brands of cephalosporins were
carried out by high pressure liquid chromatography as stated
in the BP (2009) for cefotaxime, ceftriaxone and cefuroxime
while the HPLC method stated in USP 32/NF 27 (2009) was
adopted for ceﬁxime and ceftazidime.3. Results and discussion
The structures of the ﬁve cephalosporins studied in this work
are presented in Fig. 1. All the ﬁve cephalosporins upon diaz-
otization formed immediate golden yellow color with DMABin methanol. The colors of the azo adducts became intensiﬁed
with elevated temperature. The formation of azo dye of diazo-
tized molecules with DMAB was ﬁrst reported by Adegoke
and Umoh (2009). It was observed that when the reaction is
carried out in methanol (as opposed to water), the internal
mesomeric effect of the carbonyl group is repressed and thus
giving room for the activating directing inﬂuence of the dial-
kylamino substituent on DMAB to be optimal. The end result
is the formation of a highly colored product which can be used
for the colorimetric assessment of pharmaceuticals. The meth-
od was successfully applied to the nitroimidazoles (metronida-
zole and tinidazole). The present assessment of cephalosporins
is borne out of the desire to develop relatively simple, cheaper
and easily adoptable method for the quality assessment of
these important antibacterial agents.
3.1. Selection of analytical wavelength
All the cephalosporins studied gave clearly deﬁned absorption
maxima in the visible region. Fig. 2 shows the absorption spec-
tra of the azo adducts formed between the cephalosporins and
DMAB overlaid on the spectrum of DMAB. For CEFM,
CEFU and CEZD, there were two clear-cut absorption max-
ima consisting of one high-energy band at around 320 nm
and a low-energy band at greater than 400 nm. The high-en-
ergy band may be as a result of the chromophoric tagging with
DMAB which leaves a residual peak of DMAB while the new
bands at >400 nm represents the bands due to the new azo ad-
ducts formed between the cephalosporins and DMAB. CEFT,
on the other hand, has its high-energy band at close to 270 nm.
The new visible region maxima ranged from 400 (CEFX), 420
(CEFT, CEZD and CEFU) to 430 nm (CEFM). Since diazoti-
zation is a form of derivatization methodology, the major
absorption maxima produced by the diazotized cephalosporins
were around 230 nm. Thus, the primary aim of generating col-
ored adducts that can be determined colorimetrically seems to
have been accomplished with the formation of new compounds
having absorption maxima in the visible region. The closeness
of the absorption maxima of all the cephalosporin-DMAB ad-
ducts attests to the similarity in structures of the cephalospo-
Table 5 Comparative dosage form analysis using new method and the ofﬁcial HPLC methods.
Drug formulations New methoda Oﬃcial methoda Mean recovery ± SDb (%) Error (%) Statistics (p-values) c
Concentration
found (lg mL1)
RSD (%) Concentration
found (lg mL1)
RSD (%) F-test t-test
Ceftriaxone brands
Duocef injection 39.82 1.05 39.82 0.02 100.00 ± 1.08 0 0.004 0.48
Rophex injection 40.002 0.79 39.97 0.06 100.09 ± 0.73 0.08 0.002 0.86
Ebecef injection 39.94 0.68 40.06 0.05 99.70 ± 0.64 0.30 0.002 0.28
Ceftazidime brands
Orzid injection 19.97 0.95 19.82 0.101 100.99 ± 0.95 0.76 0.004 0.13
Betazidim injection 22.64 4.33 23.52 0.094 96.61 ± 1.56 3.74 0.007 0.30
Ceﬁxime brands
Brand A (tablet) 31.14 2.51 30.28 5.38 103.86 ± 0.96 2.84 0.005 0.31
Brand B (tablet) 29.19 1.85 30.89 0.13 95.39 ± 0.91 5.50 0.10 0.34
Cefotaxime brands
Taxim-500 injection 35.51 1.29 35.46 1.07 99.24 ± 1.32 0.14 0.22 0.58
Nitaxim injection 33.87 0.86 34.11 1.30 99.36 ± 0.93 0.70 0.21 0.79
Cefuroxime brands
Axacef tablet 25.54 0.67 25.82 0.39 98.92 ± 0.72 1.08 0.37 0.06
Zocef injection 24.41 2.01 23.86 0.17 103.48 ± 1.12 2.31 0.001 0.15
Roxicef injection 25.33 1.07 25.66 0.02 98.71 ± 1.06 1.29 0.004 0.12
a Mean value, n= 6. Content of cephalosporins stated by BP ranges from 90% to 110% (cefotaxime), 92–108% (ceftriaxone) and 90–105%
(cefuroxime injection, tablet is 92.5–105%) while USP content for ceﬁxime and ceftazidime is 95–102%.
b % Recovery calculated as a ratio of the new method to the HPLC method.
c Statistical analyzes done between the results obtained from the proposed method and the BP ofﬁcial HPLC method.
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tivity and kmax of the ﬁve adducts. Thus, the cephalosporins
were determined in the colorimetric region far removed from
the non-speciﬁc absorption in the UV region. This holds prom-
ise for ready and easy determination of these important
antibiotics.
The reactions leading to the formation of the new azo ad-
ducts between the cephalosporins and DMAB are illustrated
with ceﬁxime and ceftriaxone in Scheme 1. The reaction in-
volves a two-step process, in which the cephalosporins were
diazotized with acidiﬁed NaNO2 (at 0–5 C) and then coupling
with acidiﬁed DMAB solution with methanol providing the
best reaction medium. A cursory look at the adducts produced
shows that the DMAB molecule is well staggered from the
residual cephalosporin molecules and this may account for
the extension of conjugation leading to new absorption
maxima in the visible region. However, the conjugation ap-
pears to be limited to the heterocyclic rings alone as the conju-
gation is broken beyond these rings. The predicted
stereochemistry of the azo adducts is of E-type (trans geomet-
ric isomers) which leads to a staggered conformation around
the diazenyl linkage; hence accounting for the ease of forma-
tion of the azo adducts.
3.2. Optimization studies
Several critical parameters that could affect the propensity and
the rate of the diazo coupling reaction between diazotized
cephalosporins and DMAB were studied and optimized. These
parameters include temperature, time, acid concentration,
DMAB concentration, solvent for dilution after coupling as
well as the determination of mole ratio of DMAB with respect
to the diazotized compounds.The results obtained for the optimization of temperature re-
quired for coupling are presented in Fig. 3a (CEFT, CEZD
and CEFM) and b (CEFX and CEFU). For all the ﬁve ceph-
alosporins, elevated temperature was required for optimal
reaction to occur. This is understandable as the cephalosporins
do not possess sufﬁcient activated skeletons for the reaction to
go on readily at room temperature. For CEFT and CEZD, the
absorbance readings increased gradually from 30 C and
peaked at 50 C. However, the values obtained for 5 min were
lower than that obtained at 20 min implying that a longer time
at 50 C will be required for effective coupling. For CEFM, the
value rises with increased temperature and 60 C gave the opti-
mal absorbance. For CEFT and CEZD, at temperatures be-
yond 50 C, the absorbance values produced decreased. This
might be due to thermal decomposition of the azo adducts
aided by the acidic medium in which the reaction is occurring.
Thus thermal hydrolytic cleavage of the azo adducts may be
occurring at temperatures higher than 50 C. Fig. 3b shows
the optimization of coupling reaction temperature for CEFM
and CEFU. For CEFX, the optimum temperature occurred
at 60 C and thereafter a decline was observed at 80 C.
Twenty minutes reaction time generally gave higher values
than at 5 min. For CEFU, 50 C was found optimal for the
diazo coupling reaction with 20 min reaction time giving high-
er absorptivity compared to 5 min. Thus for the optimization
of coupling reaction temperature, 50 C was optimal for the
reaction between DMAB and CEFT as well as for CEFX.
The optimal temperature for CEZD, CEFM and CEFU ad-
ducts is 60 C.
Based on the results of the optimization of coupling temper-
ature, the time required for the optimal coupling to take place
was investigated at the optimum temperature. The results of the
assessment are presented in Fig. 4 (50 C reaction temperature
S1280 O.A. Adegoke, M.O. Quadrifor CEFT and CEFX) and Fig. 5 (60 C reaction temperature
for CEFM, CEZD and CEFU). For CEFT (Fig. 4), the absor-
bance of the azo adduct increased steadily from 5 to 20 min and
thereafter declined beyond 20 min. Thus, 20 min was selected as
the optimum coupling time at 50 C. For CEFX, a not too
clearly deﬁned rise in absorbance was observed across the time
intervals. However, 20 min still appears optimal for the cou-
pling reaction and was thereafter selected. For the other three
adducts (Fig. 5), optimization of coupling reaction time gave
15 min (CEFU) and 20 min (CEFM and CEZD).
The effects of varying the concentration of H2SO4 used in
preparing the DMAB solution were investigated. For the
DMAB-cephalosporin adducts, optimal difference in absorp-
tivity was found at acid concentration of 0.0625 M. Thereafter
absorbance readings declined to the lowest value at 0.5 M
H2SO4 and attained a near plateau. Since the reaction is taking
place at elevated temperatures, the decrease in absorbance with
increasing acid concentration must be due to the hydrolytic
cleavage of the reaction product by the protons. Thus the acid
concentration for preparing DMAB was kept at 0.0625 M
H2SO4.
The diluting solvents investigated were water, methanol,
ethanol, propan-1-ol and propan-2-ol. In water, very low
absorbance values were obtained while increasing values oc-
curred in the order ethanol < propan-2-ol < propan-1-
ol < methanol. Thus highest absorptivity was found with the
use of methanol as diluting solvent for the ﬁve adducts of the
cephalosporins. The low absorbance values obtained in water
can be explained based on its ability to aid the breakdown of
the azo adducts in the presence of an acid and high temperature.
The alcohols will obviously make the azo adducts more stable
by creating a less polar medium which will prevent such hydro-
lytic decomposition from taking place while at the same time
mopping up excess proton from the medium by acting as a Le-
wis base.
The effect of DMAB concentration on the formation of azo
adducts between DMAB and diazotized cephalosporins was
studied by varying the DMAB concentration form 0.1% to
3.0% in 0.0625 M H2SO4. The DMAB had some problems dis-
solving optimally in 0.0625 M at concentrations beyond 0.5 M,
hence colloidal solutions were obtained which scattered light
and this led to increasing absorbance values as the concentra-
tion of DMAB increases. DMAB concentration between 0.1%
and 0.3% gave uniform solutions with high absorbances;
although 0.3% DMAB concentration did not give the highest
absorbance, it was utilized as the optimum concentration for
the reaction as it appears to be a limiting DMAB concentra-
tion beyond colloidal particles, in which extensively scattered
light are observed and subsequently leading to high absor-
bance values.3.3. Stoichiometric ratio determination
Using the optimized conditions, the absorbances of the azo
adducts formed by the different diazotized drugs with DMAB
were found to vary with the stoichiometric ratio of the diaz-
otized drug and DMAB. The mole ratio of 1:1 was found to
give the highest absorbance value, and therefore selected as
the stoichiometric ratio for subsequent determinations, and
the absorbance values decreased thereafter at lower and high-
er molar ratios of DMAB. This result conﬁrms the presenceand availability of only one primary aromatic amino group
for diazotization and coupling on the cephalosporin
structures.
3.4. Validation studies
Using the optimized conditions developed in this work, cali-
bration curves were prepared for each of the azo adducts of
the cephalosporins with DMAB on each of three successive
days. Various linear regression equations were obtained for
the ﬁve cephalosporins. The calibration range was from as
low as 5 lg/mL (CEZD) to the highest concentration of
60 lg/mL (CEFT). The lower the calibration range, the higher
the slope and the lower the intercept. In all the ﬁve instances,
the correlation coefﬁcient was higher than 0.9980. The various
analytical and validation parameters are summarized in Table
1 while Table 2 presents the regression analyzes for the ﬁve
adducts.
The LODs and LOQs ranged from 1.901 to 6.1525 lg/mL
and 5.76 to 18.645 lg/mL, respectively. The higher the upper
limit of the calibration range, the higher the LOD and LOQ.
The molar absorptivities were also relatively high for all the
ﬁve adducts of cephalosporins.
Accuracy and precision of the new methods were assessed
on each of three successive days using the pooled calibration
data according to the USP guidelines. Table 3 presents the in-
tra-day accuracy and precision while the inter-day data are
presented in Table 4. For the intra-day accuracy, errors ranged
from 0.08% to 5.66% with recoveries in the range of 98.7–
102.71%. When assessed between the three days, the errors
were in the range 0.07–6.02% and the recoveries in the range
99.36–106.40%. There was no interference from commonly
utilized excipients such as starch, talc, magnesium stearate
and lactose. However, higher values were obtained for sample
preparations containing gelatin. This is due to the breakdown
of gelatin by acid in the presence of water and high tempera-
ture to generate amino acids and possibly some lower peptides
which will form Schiff bases with DMAB and leading to high
absorbance values.3.5. Dosage form analyzes
The comparative analysis is presented in Table 5. All the
brands assessed passed the tests except ceﬁxime tablets that
failed the quantitative determination by both the DMAB
and HPLC methods. The results point to the need for constant
monitoring of the drug market.
The mean recoveries were determined as a ratio of the re-
sults obtained from the new method and that of the ofﬁcial
methods. The recoveries ranged from 95.39% to 103.86%
with errors in the range 0–5.5%. The recoveries for the
HPLC methods were generally higher than respective DMAB
methods for each of the cephalosporins. This is understand-
able since HPLC is a separation technique. This is also re-
ﬂected in the precision and this observation can explain
why the statistical analysis yielded probability values for
the F-ratio tests that were generally lower than 0.05. How-
ever, in all cases, the DMAB method was of equivalent accu-
racy as judged by the p-values for the Students’ test which
were generally higher than 0.05.
Novel spectrophotometric determinations of some cephalosporins following azo dye S1281Some clearly observable advantages for the new DMAB
method for the determination of cephalosporins in bulk sam-
ples and pharmaceutical dosage forms are simplicity, speed
of analysis, low cost and the method is a two-step approach
that utilizes minimal reagents without recourse to extraction
into organic solvents that can compromise accuracy. It is also
a departure from the need to hydrolyze the cephalosporins as it
is common with most visible colorimetric determination of
cephalosporins previously reported.4. Conclusions
The proposed DMAB method has advantages over other
previously reported visible spectrophotometric method with
respect to its sensitivity, which permits the determination of
very low concentration and simplicity of the procedures.
Furthermore, all the analytical reagents are inexpensive, have
excellent shelf life and are available in any analytical labora-
tory. The proposed method can be applied in quality control
laboratories for the routine analysis of the investigated drugs
in raw materials and pharmaceutical formulation and as an
in-process quality control method in pharmaceutical indus-
tries, especially for preliminary studies.References
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